Original news and analysis on international IP policy
Daniele Dionisio argues some perspectives on health and IP might change now that controversial practices at the WTO, World Bank and IMF are increasingly under pressure, and that new government policy choices and actors on the world chessboard are emerging.
An expert working group on innovative financing for research and development, meeting under the auspices of the World Health Organization, held its third and final meeting last week, with a report from the secretive group expected to be released to member states in the coming weeks, according to sources.
NAIROBI - At the headquarters of UNITAID and other groups seeking to boost access to HIV/AIDS medicine, the notion of a patent pool where drug companies would combine their intellectual property is seen as an important way to drive down drug costs.
In the Kenyan capital Nairobi, home of AIDS activist Nelson Otwoma, the patent pool is a matter of life and death.
قد تعيق مبادرات مكافحة التزييف الوصول إلى الأدوية لكنها لا تخفف مشكلة العقارات المزيفة، خصوصاً في الدول النامية، وذلك بحسب ما قاله الأعضاء المشاركون في حدث نظم مؤخراً من قبل معهد المجتمع المفتوح.
The International Federation of Pharmaceutical Manufacturers and Associations has appointed a new director general, Eduardo Pisani, to take office 1 January 2010.
World Health Organization members this week offered views on the global system for virus- and benefit-sharing for pandemic influenza following recently proposed solutions by Director General Margaret Chan aimed at changing the current, ad-hoc model to a more predictable, sustainably-funded system.
The United Nations Economic and Social Council, a key coordinating body meeting this summer in Geneva, is considering ways to move nations faster toward global public health goals, with a warning from developing countries that intellectual property rights should not interfere with access to medical products and innovation.
A conference at the World Intellectual Property Organization exploring and clarifying the connection between its work and several major public policy issues ended Tuesday with a look at public health and food security.
Interview With Ellen ‘t Hoen, Senior IP Advisor At UNITAID, author of "The Global Politics of Pharmaceutical Monopoly Power."
NAIROBI - Drug companies routinely violate World Health Organization ethical guidelines when advertising and promoting their products in East Africa, according to a new study released Thursday.
An expert body under the World Health Organization tasked with finding innovative solutions for financing research for needed medicines concluded its second official meeting Wednesday, working on a process to analyse possible mechanisms. The WHO afterward appeared to address concerns – which included a civil society letter – by insisting there would be more transparency in the negotiating process, but did not provide assurance that potential conflicts of interest would be properly addressed.
Perhaps the single most critical issue to resolve in addressing neglected diseases is how to ensure there is money to pay for research and clinical trials, even when the consumer demand is small and its constituents poor. A group of experts under the auspices of the World Health Organization this week is attempting to address the problem.